Home
Profile
About Us
Mission, Vision & Values
Exports
Future Plans
Corporate Social Responsibility
Strength
Quality
Research & Development
Facility
Products
Oral - Liquid Syrup & Suspension
Liquid Injectable (SVP)-Vials & Ampoules
Cephalosporin - Dry Powder Injections
Cephalosporin – Oral Solid
Lyophilised Injections (In Vials)
Gallery
Facility
Products
Prestigious Clients
Business Enquiry
Investor
Announcement
Annual Report
Compliances
Financial Results
Notices and Intimations
Policies
Prospectus
Shareholding Pattern
Investor Help Desk
Committees
Board of Directors
Registrar And Transfer Agent
Corporate Governance Report
Shareholders Meeting
Careers
Contact
Financial Results
Financial Results
Financial Result as on 31st Dec 2020
Financial Result as on 30th Sept 2020
Financial Result as on 30th June 2020
Financial Result as on 31st March 2020
Financial Result as on 31st Dec 2019
Financial Result as on 30th June 2019
Financial Result as on 30th Sept 2019
Financial Result as on 31st March 2019
Financial Result as on 30th Sept 2018
Financial Results as on 31st March 2018
Financial Results as on 30th Sep 2017
Financial Results as on 31st March 2017